FORT
WORTH, Texas, July 16,
2024 /PRNewswire/ -- VERTESS
(http://vertess.com), a leading healthcare mergers and acquisitions
(M&A) advisory firm, is pleased to announce the successful
completion of a third pharmacy deal this year. This deal closely
follows two additional pharmacy transactions completed in Q2.
Keystone Specialty Pharmacy (https://keystone-pharmacy.com/), a
customized, specialty pharmacy out of Mississippi, was purchased by Novastone
Capital Advisors (NCA) (https://www.novastone-ca.com/index.php), a
Switzerland-based private equity
firm, as part of their Entrepreneurship through Acquisition (ETA)
Program. Keystone prides themselves on offering health care
providers new resources to treat serious infections while also
being committed to maintaining the highest ethical standards in
business. Dr. Lisa Piercey, NCA's
Entrepreneur, will lead the pharmacy as it continues its mission of
providing critical care.
The transaction was overseen by VERTESS Managing Director,
Alan Hymowitz, who previously owned
and operated a pharmacy before his tenure at VERTESS. His unique
background was invaluable in leading this transaction to a
successful conclusion. He noted what a demanding and lengthy
process this transaction was, but that he is thrilled for his
clients to see this deal across the finish the line.
Keystone owners, Jeffrey and Kim
Clark, reflected on the transaction process sharing,
"Alan Hymowitz and the team from
VERTESS understood the importance of finding a strategic investor
who would continue our mission 'Our goal is to heal and not
refill.' VERTESS found the ideal fit for our pharmacy, one
who we have confidence will take care of our patients with
excellence while expanding the business we started. We are
extremely grateful to Alan, David
Coit, and the rest of the VERTESS team for their diligence
and expertise in bringing our deal to close. Their guidance through
this process has been a blessing to us both."
For more information, please contact Vaughne Glennie at 380413@email4pr.com or
+1.520.395.0244.
About VERTESS
VERTESS is an international healthcare-focused Mergers &
Acquisitions (M&A) advisory firm with expertise spanning
diverse healthcare and human service verticals, ranging from
behavioral health and intellectual/developmental disabilities to
DME, pharmacies, home care/hospice, urgent care, life sciences, and
other specialized services and products. Each VERTESS Managing
Director has had executive experience in either launching or
managing and ultimately successfully exiting a healthcare
company.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vertess-closes-third-pharmacy-deal-of-2024-302197257.html
SOURCE Vertess Healthcare Advisors